Ramelteon 8MG tab 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9WM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,374
Award facts
- Contract value 100% obligated
- $1,374.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,374.24 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8mg tablets (30-count) on January 15, 2026, with an ultimate completion date of January 16, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Ramelteon is a prescription medication used primarily for the treatment of insomnia. The delivery order is a child task order issued under a larger Indefinite Delivery Contract (IDC) vehicle between the Defense Logistics Agency Troop Support Medical and AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent company, Cencora, Inc., which does business as AmerisourceBergen, holds the primary $999.9 million IDC with the Defense Logistics Agency to supply a comprehensive range of pharmaceutical products and medical supplies globally. Delivery orders under this contract vehicle, such as the Ramelteon award, support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with essential medications and medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FW9WM?
SPE2DR26FW9WM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FW9WM worth?
The government has obligated $1,374 on SPE2DR26FW9WM.
Is contract SPE2DR26FW9WM an order under another contract?
Yes. SPE2DR26FW9WM is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9WM competed?
The extent of competition for SPE2DR26FW9WM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award